Gerri Henwood
2018 - Recro Pharma
In 2018, Gerri Henwood earned a total compensation of $2.4M as President and Chief Executive Officer at Recro Pharma, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $183,600 |
|---|---|
| Option Awards | $600,000 |
| Salary | $598,662 |
| Stock Awards | $1,008,000 |
| Other | $37,172 |
| Total | $2,427,434 |
Henwood received $1M in stock awards, accounting for 42% of the total pay in 2018.
Henwood also received $183.6K in non-equity incentive plan, $600K in option awards, $598.7K in salary and $37.2K in other compensation.
Rankings
In 2018, Gerri Henwood's compensation ranked 4,793rd out of 14,244 executives tracked by ExecPay. In other words, Henwood earned more than 66.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,793 out of 14,244 | 66th |
Division Manufacturing | 1,800 out of 5,765 | 69th |
Major group Chemicals And Allied Products | 654 out of 2,128 | 69th |
Industry group Drugs | 550 out of 1,817 | 70th |
Industry Pharmaceutical Preparations | 425 out of 1,391 | 69th |
Source: SEC filing on March 20, 2019.
Henwood's colleagues
We found two more compensation records of executives who worked with Gerri Henwood at Recro Pharma in 2018.
News
Baudax Bio CEO Gerri Henwood's 2021 pay jumps 178% to $1.7M
March 31, 2022
Recro Pharma CFO Ryan Lake's 2020 pay jumps 161% to $2.2M
March 25, 2021
Baudax Bio CEO Gerri Henwood's 2020 pay falls 87% to $603K
March 11, 2021
Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M
March 27, 2020
Recro Pharma CEO Gerri Henwood's 2018 pay rises 16% to $2.4M
March 20, 2019